SEC Form 4 · accession 0001104659-15-042145
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Floyd F. Petersen
Director
Period of report
May 27, 2015
Accepted (ET)
May 29, 2015 · 8:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 27, 2015 | A | 8,686 | $0.00 | A | 50,298 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $15.11 | May 27, 2015 | A | 47,782 | A | May 27, 2016 | May 27, 2020 | Common Stock | 47,782 | 47,782 | D |
Explanation of responses
- F1The reported securities are represented by deferred stock units, or DSUs, all of which vest on May 27, 2016.
- F2All of the shares subject to the option vest on May 27, 2016.